Aptahem enters into an agreement with Yorkville Advisors Global securing financing of up to MSEK 20
2018-06-27
Aptahem AB (publ), a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation are involved in the disease process, today announce its entry into an issuance agreement with...
Read More